New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane- Anchored MMPs with Therapeutic Antibodies

被引:62
作者
Devy, Laetitia [1 ]
Dransfield, Daniel T. [2 ]
机构
[1] Merck Serono SA, CH-1211 Geneva 20, Switzerland
[2] Dyax Corp, Cell Biol & Translat Res, 300 Technol Sq, Cambridge, MA 02139 USA
关键词
D O I
10.1155/2011/191670
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
MMP intervention strategies have met with limited clinical success due to severe toxicities. In particular, treatment with broadspectrum MMP-inhibitors (MMPIs) caused musculoskeletal pain and inflammation. Selectivity may be essential for realizing the clinical potential of MMPIs. Here we review discoveries pinpointing membrane-bound MMPs as mediators of mechanisms underlying cancer and inflammation and as possible therapeutic targets for prevention/treatment of these diseases. We discuss strategies to target these therapeutic proteases using highly selective inhibitory agents (i.e., human blocking antibodies) against individual membrane-bound MMPs.
引用
收藏
页数:11
相关论文
共 139 条
[1]
Identification of MMP-15 as an anti-apoptotic factor in cancer cells [J].
Abraham, R ;
Schäfer, J ;
Rothe, M ;
Bange, J ;
Knyazev, P ;
Ullrich, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) :34123-34132
[2]
Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activity [J].
Atkinson, J. M. ;
Pennington, C. J. ;
Martin, S. W. ;
Anikin, V. A. ;
Mearns, A. J. ;
Loadman, P. M. ;
Edwards, D. R. ;
Gill, J. H. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (11) :1764-1771
[3]
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].
Balbín, M ;
Fueyo, A ;
Tester, AM ;
Pendás, AM ;
Pitiot, AS ;
Astudillo, A ;
Overall, CM ;
Shapiro, SD ;
López-Otín, C .
NATURE GENETICS, 2003, 35 (03) :252-257
[4]
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[5]
The Chemokine Receptor CXCR4 and the Metalloproteinase MT1-MMP Are Mutually Required during Melanoma Metastasis to Lungs [J].
Bartolome, Ruben A. ;
Ferreiro, Sergio ;
Miquilena-Colina, Maria E. ;
Martinez-Prats, Lorena ;
Soto-Montenegro, Maria L. ;
Garcia-Bernal, David ;
Vaquero, Juan J. ;
Agami, Reuven ;
Delgado, Rafael ;
Desco, Manuel ;
Sanchez-Mateos, Paloma ;
Teixido, Joaquin .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02) :602-612
[6]
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion [J].
Belkin, AM ;
Akimov, SS ;
Zaritskaya, LS ;
Ratnikov, BI ;
Deryugina, EI ;
Strongin, AY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18415-18422
[7]
Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma [J].
Bendardaf, R ;
Lamlum, H ;
Vihinen, P ;
Ristamäki, R ;
Laine, J ;
Pyrhönen, S .
ONCOLOGY, 2003, 65 (04) :337-346
[8]
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[9]
Bernal F, 2005, BIOL RES, V38, P267, DOI 10.4067/S0716-97602005000200016
[10]
Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester [J].
Bjorn, SF ;
Hastrup, N ;
Larsen, JF ;
Lund, LR ;
Pyke, C .
PLACENTA, 2000, 21 (2-3) :170-176